Cited by 211Menstrual Health and DisordersMaternal Mental Health During Pregnancy and PostpartumMenopause: Health Impacts and Treatments

The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.

ISPMD consensus on the management of premenstrual disorders

Open access

Consensus Group of the International Society for Premenstrual Disorders, Nevatte, Tracy, O’Brien, Patrick Michael Shaughn, Bäckström, Torbjorn, Brown, Candace, Dennerstein, Lorraine, Endicott, Jean, Epperson, C. Neill, Eriksson, Elias, Freeman, Ellen W., Halbreich, Uriel, Ismail, Khalid, Panay, Nicholas, Pearlstein, Teri, Rapkin, Andrea, Reid, Robert, Rubinow, David, Schmidt, Peter, Steiner, Meir, Studd, John, Sundström-Poromaa, Inger, Yonkers, Kimberly·2013·Archives of Women s Mental Health

DOI 10.1007/s00737-013-0346-yPMC PMC3955202

Open this paper in CoChat — free account

Abstract

The second consensus meeting of the International Society for Premenstrual Disorders (ISPMD) took place in London during March 2011. The primary goal was to evaluate the published evidence and consider the expert opinions of the ISPMD members to reach a consensus on advice for the management of premenstrual disorders. Gynaecologists, psychiatrists, psychologists and pharmacologists each formally presented the evidence within their area of expertise; this was followed by an in-depth discussion leading to consensus recommendations. This article provides a comprehensive review of the outcomes from the meeting. The group discussed and agreed that careful diagnosis based on the recommendations and classification derived from the first ISPMD consensus conference is essential and should underlie the appropriate management strategy. Options for the management of premenstrual disorders fall under two broad categories, (a) those influencing central nervous activity, particularly the modulation of the neurotransmitter serotonin and (b) those that suppress ovulation. Psychotropic medication, such as selective serotonin reuptake inhibitors, probably acts by dampening the influence of sex steroids on the brain. Oral contraceptives, gonadotropin-releasing hormone agonists, danazol and estradiol all most likely function by ovulation suppression. The role of oophorectomy was also considered in this respect. Alternative therapies are also addressed, with, e.g. cognitive behavioural therapy, calcium supplements and Vitex agnus castus warranting further exploration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00737-013-0346-y

Cites

114 of 114 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225
The Premenstrual Syndrome
Greene, R., & Dalton, K. (1953) · BMJ · doi:10.1136/bmj.1.4818.1007 · Cited by 1,819
A double‐blind, placebo‐controlled trial
Pinals, R. S., Kaplan, S. B., Lawson, J. G., & Hepburn, B. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291202 · Cited by 1,355
GABAA receptors: Subtypes provide diversity of function and pharmacology
Olsen, R. W., & Sieghart, W. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.045 · Cited by 986
Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome
Schmidt, P. J., Nieman, L. K., Danaceau, M. A., Adams, L. F., & Rubinow, D. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801223380401 · Cited by 765
Self-citation
The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD)
Halbreich, U. M., Borenstein, J. E., Pearlstein, T., & Kahn, L. S. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00098-2 · Cited by 758
The premenstrual symptoms screening tool (PSST) for clinicians
Steiner, M., Macdougall, M., & Brown, E. (2003) · Archives of Women's Mental Health · doi:10.1007/s00737-003-0018-4 · Cited by 641
Self-citation
Premenstrual syndrome
Yonkers, K. A., O’Brien, P. M. S., & Eriksson, E. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60527-9 · Cited by 593
Prevalence, incidence and stability of premenstrual dysphoric disorder in the community
WITTCHEN, H.-U., BECKER, E., LIEB, R., & KRAUSE, P. (2002) · Psychological Medicine · doi:10.1017/s0033291701004925 · Cited by 554
Daily Record of Severity of Problems (DRSP): reliability and validity
Endicott, J., Nee, J., & Harrison, W. M. (2005) · Archives of Women s Mental Health · doi:10.1007/s00737-005-0103-y · Cited by 483
Cortical γ-Aminobutyric Acid Levels Across the Menstrual Cycle in Healthy Women and Those With Premenstrual Dysphoric Disorder
Epperson, C. N., Haga, K. K., Mason, G. F., Sellers, E. M., Gueorguieva, R. V., Zhang, W., Weiss, E. L., Rothman, D. L., & Krystal, J. H. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.9.851 · Cited by 402
Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: A systematic review
Dimmock, P. W., Wyatt, K. M., Jones, P. W., & O'Brien, P. S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02754-9 · Cited by 368 · cited 3×
“…IH -PA Author M anuscript first-line therapy for PMS and PMDD (Shah et al. 2008), and this approach is supported by the evidence generated from numerous individual trials and by a meta-analysis of 29 randomised, placebo-controlled clinical trials (Dimmock et al. 2000; Brown et al. 2009).”
Premenstrual dysphoric disorder: Evidence for a new category for DSM-5
Epperson, C. N., Steiner, M., Hartlage, S. A., Eriksson, E., Schmidt, P. J., Jones, I., & Yonkers, K. A. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11081302 · Cited by 361
Efficacy of a New Low-Dose Oral Contraceptive With Drospirenone in Premenstrual Dysphoric Disorder
Yonkers, K. A., Brown, C., Pearlstein, T. B., Foegh, M. L., Sampson-Landers, C., & Rapkin, A. J. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000175834.77215.2e · Cited by 349
A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation
Sanders, S. A., Graham, C. A., Bass, J. L., & Bancroft, J. (2001) · Contraception · doi:10.1016/s0010-7824(01)00218-9 · Cited by 347
Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus
O’Brien, P. M. S., Bäckström, T. C., Brown, C., Dennerstein, L., Endicott, J., Epperson, C. N., Eriksson, E., Freeman, E. W., Halbreich, U. M., ISMAIL, K. M. K., et al. (2011) · Archives of Women s Mental Health · doi:10.1007/s00737-010-0201-3 · Cited by 302
The epidemiology of perimenstrual psychological symptoms
Angst, J., Sellaro, R., Stolar, M. J., Merikangas, K. R., & Endicott, J. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00412.x · Cited by 300
Calcium carbonate and the premenstrual syndrome: Effects on premenstrual and menstrual symptoms
Thys‐Jacobs, S., Starkey, P., Bernstein, D., & Tian, J. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70377-1 · Cited by 297
Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation
Pearlstein, T. B., Bachmann, G. A., Zacur, H. A., & Yonkers, K. A. (2005) · Contraception · doi:10.1016/j.contraception.2005.08.021 · Cited by 278
Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review
Wyatt, K. M., Dimmock, P. W., Jones, P. W., & O’Brien, P. M. S. (1999) · BMJ · doi:10.1136/bmj.318.7195.1375 · Cited by 277
Oral contraceptives containing drospirenone for premenstrual syndrome
Lopez, L. M., Kaptein, A. A., & Helmerhorst, F. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006586.pub4 · Cited by 275
Neurosteroids: biochemistry, modes of action, and clinical relevance.
Mellon, S. H. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.5.8175951 · Cited by 272
To what extent do oral contraceptives influence mood and affect?
Oinonen, K. A., & Mazmanian, D. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00356-1 · Cited by 268
The Premenstrual Syndrome
Muse, K. N., Cetel, N. S., Futterman, L. A., & Yen, S. S. C. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411223112104 · Cited by 268
Mood, Sexuality, Hormones, and the Menstrual Cycle. II. Hormone Levels and Their Relationship to the Premenstrual Syndrome
Bäckström, T. C., Sanders, D., Leask, R., Davidson, D., Warner, P., & Bancroft, J. (1983) · Psychosomatic Medicine · doi:10.1097/00006842-198312000-00004 · Cited by 266
Biological, Social, and Behavioral Factors Associated With Premenstrual Syndrome
Deuster, P. A. (1999) · Archives of Family Medicine · doi:10.1001/archfami.8.2.122 · Cited by 244
Calcium carbonate and the premenstrual syndrome:Effects on premenstrual and menstrual symptoms.
孙爱军, 孔桂英, & 董瑞峰 (2001) · doi:10.3760/cma.j.issn.1674-635x.2001.01.024 · Cited by 225
Prevalene of perimenstrual symptoms.
Woods, N. F., Most, A., & Dery, G. K. (1982) · American Journal of Public Health · doi:10.2105/ajph.72.11.1257 · Cited by 217
The Serotonin Reuptake Inhibitor Paroxetin Is Superior to the Noradrenaline Reuptake Inhibitor Maprotiline in the Treatment of Premenstrual Syndrome
Eriksson, E., Hedberg, M. A., Andersch, B., & Sundblad, C. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00076-c · Cited by 212
Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women
Cohen, L. S., Soares, C. N., Otto, M. W., Sweeney, B. H., Liberman, R. F., & Harlow, B. L. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00458-x · Cited by 209
Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators
Andréen, L., Nyberg, S., Turkmen, S., van Wingen, G. A., Fernández, G., & Bäckström, T. C. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.02.003 · Cited by 196
Sleep, hormones, and circadian rhythms throughout the menstrual cycle in healthy women and women with premenstrual dysphoric disorder
Shechter, A., & Boivin, D. B. (2010) · International Journal of Endocrinology · doi:10.1155/2010/259345 · Cited by 194
TREATMENT OF SEVERE PREMENSTRUAL SYNDROME WITH OESTRADIOL PATCHES AND CYCLICAL ORAL NORETHISTERONE
Watson, N., Savvas, M., Studd, J. W. W., GARNETT, T. J., & Baber, R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90784-8 · Cited by 193
The effectiveness of GnRHa with and without ‘add‐back’ therapy in treating premenstrual syndrome: a meta analysis
Wyatt, K. M., Dimmock, P. W., ISMAIL, K. M. K., Jones, P. W., & O’Brien, P. M. S. (2004) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2004.00135.x · Cited by 188
Selective serotonin reuptake inhibitors for premenstrual syndrome.
Marjoribanks, J., Brown, J., O'Brien, P., & Wyatt, K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001396.pub3 · Cited by 180
Differential Response to Antidepressants in Women With Premenstrual Syndrome/Premenstrual Dysphoric Disorder
Freeman, E. W., Rickels, K., Sondheimer, S. J., & Polansky, M. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.10.932 · Cited by 176
Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral norethisterone: placebo controlled study.
Magos, A. L., Brincat, M., & Studd, J. W. W. (1986) · BMJ · doi:10.1136/bmj.292.6536.1629 · Cited by 176
Psychoneuroendocrinology
Campeau, S. (2002) · Elsevier eBooks · doi:10.1016/b0-12-227210-2/00291-0 · Cited by 174
Lack of Effect of Induced Menses on Symptoms in Women with Premenstrual Syndrome
Schmidt, P. J., Nieman, L. K., Grover, G. N., Muller, K. L., Merriam, G. R., & Rubinow, D. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241705 · Cited by 172
Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons
Bäckström, T., Haage, D., Löfgren, M., Johansson, I. M., Strömberg, J., Nyberg, S., Andréen, L., Ossewaarde, L., van Wingen, G. A., Turkmen, S., et al. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.061 · Cited by 169
The Effect of a Carbohydrate-Rich Beverage on Mood, Appetite, and Cognitive Function in Women With Premenstrual Syndrome
Sayegh, R. A., SCHIFF, I., Wurtman, J. J., Spiers, P. A., Mcdermott, J., & Wurtman, R. J. (1995) · Obstetrics and Gynecology · doi:10.1016/0029-7844(95)00246-n · Cited by 163
Induced Anovulation As Treatment Of Premenstrual Tension Syndrome: A double‐blind cross‐over study with GnRH‐agonist versus placebo
Hammarbäck, S., & Bäckström, T. C. (1988) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348809004191 · Cited by 163
Late luteal phase dysphoric disorder in young women
Rivera-Tovar, A., & Frank, E. F. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.12.1634 · Cited by 162
Evaluation of a Unique Oral Contraceptive in the Treatment of Premenstrual Dysphoric Disorder
Freeman, E. W., Kroll, R., Rapkin, A. J., Pearlstein, T. B., Brown, C., Parsey, K., Zhang, P. J., Patel, H., & Foegh, M. L. (2001) · Journal of Women s Health & Gender-Based Medicine · doi:10.1089/15246090152543148 · Cited by 162
Clomipramine Administered during the Luteal Phase Reduces the Symptoms of Premenstrual Syndrome: A Placebo-Controlled Trial
Sundblad, C., Hedberg, M. A., & Eriksson, E. (1993) · Neuropsychopharmacology · doi:10.1038/npp.1993.52 · Cited by 161
The epidemiology of premenstrual symptoms in A population-based sample of 2650 urban women: Attributable risk and risk factors
Ramcharan, S., Love, E. J., Fick, G. H., & Goldfien, A. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90039-p · Cited by 158
The premenstrual symptoms screening tool revised for adolescents (PSST-A): prevalence of severe PMS and premenstrual dysphoric disorder in adolescents
Steiner, M. S., Peer, M., Pálová, E., Freeman, E. W., Macdougall, M., & Soares, C. N. (2011) · Archives of Women s Mental Health · doi:10.1007/s00737-010-0202-2 · Cited by 152
A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive
Graham, C. A., & Sherwin, B. B. (1992) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(92)90090-o · Cited by 148
Lasting response to ovariectomy in severe intractable premenstrual syndrome
Casson, P. R., Hahn, P. M., Vugt, D. A. V., & Reid, R. L. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90830-z · Cited by 147
Comparison of Fluoxetine, Bupropion, and Placebo in the Treatment of Premenstrual Dysphoric Disorder
Pearlstein, T. B., Stone, A. B., Lund, S. A., Scheft, H., Zlotnick, C., & Brown, W. A. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199708000-00004 · Cited by 142
Neurosteroids: biochemistry, modes of action, and clinical relevance
Mellon, S. H. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1003 · Cited by 136
Review: problems associated with long-term treatment with selective serotonin reuptake inhibitors
Moret, C., Isaac, M., & Briley, M. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108093582 · Cited by 135
The effect of hysterectomy and bilateral oophorectomy in women with severe premenstrual syndrome
Casper, R. F., & Hearn, M. T. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90831-q · Cited by 133
Cognitive-behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review
Lustyk, M. K. B., Gerrish, W. G., Shaver, S., & Keys, S. L. (2009) · Archives of Women s Mental Health · doi:10.1007/s00737-009-0052-y · Cited by 133 · cited 1×
“Reviews of randomised controlled trials (RCTs) of CBT studies suggest weak superiority compared to placebo or wait-list controls (see reviews, Busse et al. 2009; Lustyk et al. 2009).”
Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries
Cohen, L. S. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02166-x · Cited by 133
Selective Serotonin Reuptake Inhibitors for Premenstrual Syndrome and Premenstrual Dysphoric Disorder: A Meta-Analysis
Shah, N., Jones, J. B., Aperi, J., Shemtov, R., Karne, A., & Borenstein, J. (2008) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31816fd73b · Cited by 130
Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behavior.
Johnson, S. R., McChesney, C., & Bean, J. A. (1988) · PubMed · Cited by 129
Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome
Cronje, W. (2004) · Human Reproduction · doi:10.1093/humrep/deh354 · Cited by 128
Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase–only danazol
O’Brien, P. M. S., & Abukhalil, I. E. H. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70142-0 · Cited by 127
Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.
Steiner, M. S., & Pearlstein, T. B. (2000) · PubMed · Cited by 125
Efficacy of Intermittent, Luteal Phase Sertraline Treatment of Premenstrual Dysphoric Disorder
Halbreich, U. M., Bergeron, R., Yonkers, K. A., Freeman, E., Stout, A. L., & Cohen, L. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02326-8 · Cited by 125
Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives
SVEINDÓTTIR, H., & Bäckström, T. C. (2000) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/j.1600-0412.2000.079005405.x · Cited by 117
Selective serotonin reuptake inhibitors for premenstrual syndrome
Brown, J., O’Brien, P. M. S., Marjoribanks, J., & Wyatt, K. M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001396.pub2 · Cited by 115
Self-citation
Exercise and Premenstrual Symptomatology: A Comprehensive Review
Daley, A. (2009) · Journal of Women s Health · doi:10.1089/jwh.2008.1098 · Cited by 113
PERSISTENCE OF SYMPTOMS OF PREMENSTRUAL TENSION IN HYSTERECTOMIZED WOMEN
Bäckströum, C. T., Boyle, H., & Baird, D. T. (1981) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1981.tb01028.x · Cited by 105
Premenstrual Complaints. I. Prevalence of Premenstrual Symptoms in a Swedish Urban Population
Andersch, B., Wendestam, C., Hahn, L., & Öhman, R. (1986) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.3109/01674828609016741 · Cited by 104
Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder
Segebladh, B., Borgström, A., Nyberg, S., Bixo, M., & Poromaa, I. S. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.03.016 · Cited by 100
Herbal treatments for alleviating premenstrual symptoms: a systematic review
Dante, G., & Facchinetti, F. (2010) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.3109/0167482x.2010.538102 · Cited by 99
Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen
Poromaa, I. S., Nyberg, S., Bixo, M., Hammarbäck, S., & Bäckström, T. C. (1999) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.1999.781011.x · Cited by 99
An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome
Freeman, E. W., Halbreich, U. M., Grubb, G. S., Rapkin, A. J., Skouby, S. O., Smith, L. M., Mirkin, S., & Constantine, G. D. (2011) · Contraception · doi:10.1016/j.contraception.2011.09.010 · Cited by 98
Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.
Freeman, E. W., Sondheimer, S. J., & Rickels, K. (1997) · PubMed · Cited by 97
Psychological intervention for premenstrual syndrome: a meta-analysis of randomized controlled trials
Busse, J. W., Montori, V. M., Krasnik, C., Patelis-Siotis, I., & Guyatt, G. H. (2009) · Psychotherapy and Psychosomatics · doi:10.1159/000162296 · Cited by 96
Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: A randomized, double-blind, placebo-controlled clinical trial
Miner, C. M., Brown, E., McCray, S., Gonzales, J. S., & Wohlreich, M. M. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85043-3 · Cited by 95
Placebo-Controlled Trial Comparing Intermittent and Continuous Paroxetine in Premenstrual Dysphoric Disorder
Landén, M., Nissbrandt, H., Allgulander, C., Sörvik, K., Ysander, C., & Eriksson, E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301216 · Cited by 95
Oral contraceptives in premenstrual syndrome: A randomized comparison of triphasic and monophasic preparations
Bäckström, T. C., Hansson-Malmström, Y., Lindhe, B.-Å., Cavalli-Björkman, B., & Nordenström, S. (1992) · Contraception · doi:10.1016/0010-7824(92)90006-f · Cited by 92
Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial.
Brown, C., Ling, F. W., Andersen, R. N., Rg, F., & Arheart, K. L. (1994) · PubMed · Cited by 90
A randomised comparison over 8 months of 100 μg and 200 μg twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome
Smith, R. N. J., Studd, J. W. W., Zamblera, D., & Holland, E. F. N. (1995) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1995.tb11321.x · Cited by 90
Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome
Mezrow, G., Shoupe, D., Spicer, D. V., Løbo, R. A., Leung, B. V., & Pike, M. C. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57053-8 · Cited by 89
Criteria for Premenstrual Dysphoric Disorder
Hartlage, S. A. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1368 · Cited by 88
Alprazolam in the Treatment of Premenstrual Syndrome
Schmidt, P. J. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820180069007 · Cited by 83
Using the daily record of severity of problems as a screening instrument for premenstrual syndrome
Borenstein, J. E., Dean, B. B., Yonkers, K. A., & Endicott, J. (2007) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000259920.73000.3b · Cited by 76
Medical (fluoxetine) and psychological (cognitive–behavioural therapy) treatment for premenstrual dysphoric disorder
Hunter, M. S., Ussher, J. M., Cariss, M., Browne, S., Jelley, R., & Katz, M. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00338-0 · Cited by 70
Increase of Estrogen Dose Deteriorates Mood during Progestin Phase in Sequential Hormonal Therapy
Björn, I., Poromaa, I. S., Bixo, M., Nyberg, S., Bäckström, G., & Bäckström, T. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020755 · Cited by 70
Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review.
Whelan, A. M., Jurgens, T. M., & Naylor, H. (2009) · PubMed · Cited by 70
A randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome
Hahn, P. M., Vugt, D. A. V., & Reid, R. L. (1995) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)00053-d · Cited by 68
A guide to the treatment of depression in women by estrogens
Studd, J. W. W. (2011) · Climacteric · doi:10.3109/13697137.2011.609285 · Cited by 66
The treatment of severe premenstrual syndrome with goserelin with and without ‘add-back’ estrogen therapy: A placebo-controlled study
Leather, A. T., Studd, J. W. W., Watson, N., & Holland, E. F. N. (1999) · Gynecological Endocrinology · doi:10.1080/09513599909167531 · Cited by 65
Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen
Sundström, I., Nyberg, S., Bixo, M., et al. (1999) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/j.1600-0412.1999.781011.x · Cited by 64
Oral contraceptives and mood in women with and without premenstrual dysphoria: a theoretical model
Kurshan, N., & Epperson, C. N. (2005) · Archives of Women s Mental Health · doi:10.1007/s00737-005-0102-z · Cited by 63
The effect of premenstrual symptoms on activities of daily life
Dennerstein, L., Lehert, P., Bäckström, T. C., & Heinemann, K. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.04.023 · Cited by 62
Global study of women's experiences of premenstrual symptoms and their effects on daily life
Dennerstein, L., Lehert, P., & Heinemann, K. (2011) · Menopause international · doi:10.1258/mi.2011.011027 · Cited by 57
Escitalopram Administered in the Luteal Phase Exerts a Marked and Dose-Dependent Effect in Premenstrual Dysphoric Disorder
Eriksson, E., Ekman, A., Sinclair, S., Sörvik, K., Ysander, C., Mattson, U.-B., & Nissbrandt, H. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181678a28 · Cited by 57
Persistence of premenstrual syndrome during low-dose administration of the progesterone antagonist RU 486.
Chan, A. F., Mortola, J. F., Wood, S. H., & Yen, S. S. C. (1994) · PubMed · Cited by 56
The premenstrual syndrome.
Reid, R. L., & Yen, S. S. C. (1983) · PubMed · Cited by 54
Characteristics of Women with Premenstrual Dysphoric Disorder (PMDD) Who Did or Did Not Report History of Depression: A Preliminary Report from the Harvard Study of Moods and Cycles
Soares, C. N., Cohen, L. S., Otto, M. W., & Harlow, B. L. (2001) · Journal of Women s Health & Gender-Based Medicine · doi:10.1089/152460901753285778 · Cited by 54
Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome
Mitwally, M. F. M., Gotlieb, L., & Casper, R. F. (2002) · Menopause · doi:10.1097/00042192-200207000-00004 · Cited by 53
Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorder
Halbreich, U. M., Freeman, E. W., Rapkin, A. J., Cohen, L. S., Grubb, G. S., Bergeron, R., Smith, L., Mirkin, S., & Constantine, G. D. (2011) · Contraception · doi:10.1016/j.contraception.2011.05.008 · Cited by 52
Essential fatty acids for premenstrual syndrome and their effect on prolactin and total cholesterol levels: a randomized, double blind, placebo-controlled study
Filho, E. A. R., Lima, J. C., Neto, J. S. P., & Montarroyos, U. R. (2011) · Reproductive Health · doi:10.1186/1742-4755-8-2 · Cited by 51
Buserelin in premenstrual syndrome
Hussain, S. Y., Massil, J. H., MATTA, W. H. M., Shaw, R. W., & O’Brien, P. M. S. (1992) · Gynecological Endocrinology · doi:10.3109/09513599209081007 · Cited by 51
Effect of treatment with dydrogesterone or calcium plus vitamin D on the severity of premenstrual syndrome
Khajehei, M., Abdali, K., Parsanezhad, M. E., & Tabatabaee, H. R. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.01.016 · Cited by 45
Treatment of premenstrual syndrome with a carbohydrate-rich beverage
Freeman, E. W., Stout, A. L., Endicott, J., & Spiers, P. A. (2002) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(02)00033-4 · Cited by 43
Endocrinology: Ovarian suppression with the gonadotrophin-releasing hormone agonist goserelin (Zoladex) in management of the premenstrual tension syndrome
West, C. P., & Hillier, H. (1994) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a138633 · Cited by 39
Clinical Subtypes of Premenstrual Syndrome and Responses to Sertraline Treatment
Freeman, E. W., Sammel, M. D., Lin, H., Rickels, K., & Sondheimer, S. J. (2011) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e318236edf2 · Cited by 39
Depressive symptoms as predictors of discontinuation of treatment of menorrhagia by levonorgestrel-releasing intrauterine system
Elovainio, M. J., Teperi, J., Aalto, A., Grénman, S., Kivelä, A., Kujansuu, E., Vuorma, S., Yliskoski, M. H., Paavonen, J. A., & Hurskainen, R. (2007) · International Journal of Behavioral Medicine · doi:10.1007/bf03004171 · Cited by 38
Oral contraceptives containing drospirenone for premenstrual syndrome
Lopez, L. M., Kaptein, A. A., & Helmerhorst, F. M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006586.pub3 · Cited by 30
Predicting response to leuprolide of women with premenstrual dysphoric disorder by daily mood rating dynamics
Pincus, S. M., Alam, S., Rubinow, D. R., Bhuvaneswar, C. G., & Schmidt, P. J. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.07.006 · Cited by 28
Late, but not early, wake therapy reduces morning plasma melatonin: Relationship to mood in Premenstrual Dysphoric Disorder
Parry, B. L., Meliska, C. J., Martínez, L. F., López, A. M. V., Sorenson, D. L., Hauger, R. L., & Elliott, J. A. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.11.017 · Cited by 24
Low dose danazol in the treatment of the premenstrual syndrome
Deeny, M., Hawthorn, R. J. S., & Hart, D. M. (1991) · Postgraduate Medical Journal · doi:10.1136/pgmj.67.787.450 · Cited by 24
An evidence-based review updating the various treatment and management approaches to serotonin reuptake inhibitor-associated sexual dysfunction
Nurnberg, H. G. (2008) · Drugs of today · doi:10.1358/dot.2008.44.2.1191059 · Cited by 23
A Demographic Study in Subgroups of Women Seeking Help for Premenstrual Syndrome
Hammarbäck, S., & Bäckström, T. C. (1989) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348909020997 · Cited by 21
Asian study of effects of premenstrual symptoms on activities of daily life
Dennerstein, L., Lehert, P., Keung, L. S., Pal, S. A., & Choi, D. (2010) · Menopause international · doi:10.1258/mi.2010.010035 · Cited by 19
Potential strategies to avoid progestogen-induced premenstrual disorders
Baker, L. J., & O’Brien, P. M. S. (2012) · Menopause international · doi:10.1258/mi.2012.012016 · Cited by 17
Managing Common Side Effects of SSRIs
Howland, R. H. (2007) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20070201-04 · Cited by 7

Research works printed but not linked: 1

Sayegh R, Schiff I, Wurtman J, Spiers P, McDermott J, Wurtman R (1995) The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome. Obstet Gynecol 86:520–8 · DOI

Sorted by citations

Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: A systematic review
Toffoletto, S., Lanzenberger, R. R., Gingnell, M., Poromaa, I. S., & Comasco, E. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.07.025 · Cited by 331
Menstrual cycle influence on cognitive function and emotion processingâ€”from a reproductive perspective
SundstrÃ¶m Poromaa, I., & Gingnell, M. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00380 · Cited by 291
Premenstrual syndrome: A mini review
Ryu, A., & Kim, T. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.08.010 · Cited by 250
Progesterone – Friend or foe?
Poromaa, I. S., Comasco, E., Sumner, R. L., & Eileen Luders, A. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100856 · Cited by 217
Cognition, The Menstrual Cycle, and Premenstrual Disorders: A Review
Le, J., Thomas, N., & Gurvich, C. (2020) · Brain Science · doi:10.3390/brainsci10040198 · Cited by 126

See all 211

Authors: Consensus Group of the International Society for Premenstrual Disorders, Nevatte, T., O’Brien, P. M. S., Bäckström, T., Brown, C., Dennerstein, L., Endicott, J., Epperson, C. N., Eriksson, E., Freeman, E. W., Halbreich, U., Ismail, K., Panay, N., Pearlstein, T., Rapkin, A., Reid, R., Rubinow, D., Schmidt, P., Steiner, M., Studd, J., Sundström-Poromaa, I., & Yonkers, K.
Affiliations: Keele University (GB)
Royal Stoke University Hospital (GB)
University of Tennessee Health Science Center (US)
The University of Melbourne (AU)
Columbia University (US)
University of Pennsylvania (US)
University at Buffalo, State University of New York (US)
Queen Charlotte's and Chelsea Hospital (GB)
Brown University (US)
University of California, Los Angeles (US)
University of North Carolina at Chapel Hill (US)
National Institute of Mental Health (US)
Chelsea and Westminster Hospital (GB)
Uppsala University (SE)
Corresponding author: Nevatte, Tracy
ORCID: Nevatte, Tracy
Epperson, C. Neill
Eriksson, Elias
Freeman, Ellen W.
Halbreich, Uriel
Panay, Nicholas
Rapkin, Andrea
Reid, Robert
Rubinow, David
Schmidt, Peter
Steiner, Meir
Yonkers, Kimberly
Venue: Archives of Women s Mental Health
Publisher: Springer Science and Business Media LLC
Published: 2013-04-27
Volume: 16
Issue: 4
Pages: 279-291
ISSN: 1434-1816 (ISSN-L)
1435-1102
DOI: 10.1007/s00737-013-0346-y
PMC: PMC3955202
OpenAlex: W2024556146
Cited by: 211
References: 111
Citations by year: 2026: 8 · 2025: 13 · 2024: 16 · 2023: 21 · 2022: 16 · 2021: 17 · 2020: 45 · 2019: 16 · 2018: 5 · 2017: 19 · 2016: 10 · 2015: 14 · 2014: 10 · 2013: 1
FWCI: 11.90
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Archives of Women s Mental Health (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
UNC Libraries
Funders: National Institutes of Health
National Institute of Mental Health (ZIAMH002865)
National Institute on Drug Abuse (K24DA030301, R01DA018359)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords: premenstrual disorders, premenstrual dysphoric disorder, premenstrual syndrome, management recommendations, serotonin modulation, selective serotonin reuptake inhibitors, ovulation inhibition, oral contraceptives, GnRH agonist, danazol, estradiol, oophorectomy, sex steroids, cognitive behavioral therapy, calcium supplementation, Vitex agnus-castus, complementary and alternative medicine, diagnosis and classification
MeSH terms: Female, Group Processes, Humans, Premenstrual Syndrome, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

ISPMD consensus on the management of premenstrual disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks